No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
H.C. Wainwright Maintains Spruce Biosciences(SPRB.US) With Hold Rating
Hold Rating for Spruce Biosciences Amid Clinical Setbacks and Strategic Uncertainties
Spruce Biosciences (SPRB) Upgraded to Buy: Here's Why
Guggenheim Reiterates Neutral on Spruce Biosciencesto Neutral
RBC Capital Maintains Spruce Biosciences(SPRB.US) With Hold Rating, Cuts Target Price to $1.5
Oppenheimer Maintains Spruce Biosciences(SPRB.US) With Hold Rating
No Data